Cargando…

DrugRep: an automatic virtual screening server for drug repurposing

Computationally identifying new targets for existing drugs has drawn much attention in drug repurposing due to its advantages over de novo drugs, including low risk, low costs, and rapid pace. To facilitate the drug repurposing computation, we constructed an automated and parameter-free virtual scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Jian-hong, Liu, Ji-xiang, Liu, Yang, Chen, Shu-wen, Dai, Wen-tao, Xiao, Zhi-Xiong, Cao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549438/
https://www.ncbi.nlm.nih.gov/pubmed/36216900
http://dx.doi.org/10.1038/s41401-022-00996-2
_version_ 1784805671905001472
author Gan, Jian-hong
Liu, Ji-xiang
Liu, Yang
Chen, Shu-wen
Dai, Wen-tao
Xiao, Zhi-Xiong
Cao, Yang
author_facet Gan, Jian-hong
Liu, Ji-xiang
Liu, Yang
Chen, Shu-wen
Dai, Wen-tao
Xiao, Zhi-Xiong
Cao, Yang
author_sort Gan, Jian-hong
collection PubMed
description Computationally identifying new targets for existing drugs has drawn much attention in drug repurposing due to its advantages over de novo drugs, including low risk, low costs, and rapid pace. To facilitate the drug repurposing computation, we constructed an automated and parameter-free virtual screening server, namely DrugRep, which performed molecular 3D structure construction, binding pocket prediction, docking, similarity comparison and binding affinity screening in a fully automatic manner. DrugRep repurposed drugs not only by receptor-based screening but also by ligand-based screening. The former automatically detected possible binding pockets of the receptor with our cavity detection approach, and then performed batch docking over drugs with a widespread docking program, AutoDock Vina. The latter explored drugs using seven well-established similarity measuring tools, including our recently developed ligand-similarity-based methods LigMate and FitDock. DrugRep utilized easy-to-use graphic interfaces for the user operation, and offered interactive predictions with state-of-the-art accuracy. We expect that this freely available online drug repurposing tool could be beneficial to the drug discovery community. The web site is http://cao.labshare.cn/drugrep/.
format Online
Article
Text
id pubmed-9549438
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-95494382022-10-11 DrugRep: an automatic virtual screening server for drug repurposing Gan, Jian-hong Liu, Ji-xiang Liu, Yang Chen, Shu-wen Dai, Wen-tao Xiao, Zhi-Xiong Cao, Yang Acta Pharmacol Sin Article Computationally identifying new targets for existing drugs has drawn much attention in drug repurposing due to its advantages over de novo drugs, including low risk, low costs, and rapid pace. To facilitate the drug repurposing computation, we constructed an automated and parameter-free virtual screening server, namely DrugRep, which performed molecular 3D structure construction, binding pocket prediction, docking, similarity comparison and binding affinity screening in a fully automatic manner. DrugRep repurposed drugs not only by receptor-based screening but also by ligand-based screening. The former automatically detected possible binding pockets of the receptor with our cavity detection approach, and then performed batch docking over drugs with a widespread docking program, AutoDock Vina. The latter explored drugs using seven well-established similarity measuring tools, including our recently developed ligand-similarity-based methods LigMate and FitDock. DrugRep utilized easy-to-use graphic interfaces for the user operation, and offered interactive predictions with state-of-the-art accuracy. We expect that this freely available online drug repurposing tool could be beneficial to the drug discovery community. The web site is http://cao.labshare.cn/drugrep/. Springer Nature Singapore 2022-10-10 2023-04 /pmc/articles/PMC9549438/ /pubmed/36216900 http://dx.doi.org/10.1038/s41401-022-00996-2 Text en © The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
spellingShingle Article
Gan, Jian-hong
Liu, Ji-xiang
Liu, Yang
Chen, Shu-wen
Dai, Wen-tao
Xiao, Zhi-Xiong
Cao, Yang
DrugRep: an automatic virtual screening server for drug repurposing
title DrugRep: an automatic virtual screening server for drug repurposing
title_full DrugRep: an automatic virtual screening server for drug repurposing
title_fullStr DrugRep: an automatic virtual screening server for drug repurposing
title_full_unstemmed DrugRep: an automatic virtual screening server for drug repurposing
title_short DrugRep: an automatic virtual screening server for drug repurposing
title_sort drugrep: an automatic virtual screening server for drug repurposing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549438/
https://www.ncbi.nlm.nih.gov/pubmed/36216900
http://dx.doi.org/10.1038/s41401-022-00996-2
work_keys_str_mv AT ganjianhong drugrepanautomaticvirtualscreeningserverfordrugrepurposing
AT liujixiang drugrepanautomaticvirtualscreeningserverfordrugrepurposing
AT liuyang drugrepanautomaticvirtualscreeningserverfordrugrepurposing
AT chenshuwen drugrepanautomaticvirtualscreeningserverfordrugrepurposing
AT daiwentao drugrepanautomaticvirtualscreeningserverfordrugrepurposing
AT xiaozhixiong drugrepanautomaticvirtualscreeningserverfordrugrepurposing
AT caoyang drugrepanautomaticvirtualscreeningserverfordrugrepurposing